Plain-English translation of NCT06033950 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called to see if it can help people with heart failure who have a weakened heart and cannot take or do not tolerate the standard medications usually prescribed for this condition. works in a similar way to some older heart medications but may be easier for some patients to tolerate. About 2,600 people will participate in this international trial.
Many people with heart failure benefit from a specific type of heart medication, but some patients cannot tolerate it or have medical reasons they cannot take it. This trial aims to find out whether this medication offers a safe and effective option for those patients.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will be randomly assigned to receive either or a placebo (a pill with no active medication) — neither you nor the study team will know which one you are taking. You will take a daily pill and attend regular clinic visits for heart monitoring, blood work, and check-ins on how you are feeling. The study will track how your heart function changes and whether you experience any side effects over the course of the trial.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States
Brazil